Pfizer Inc. (PFE)
PFE · Health Care · 
United States
Pfizer Inc. (PFE) is a US company in the Health Care sector. The stock has its largest weight in XUHL (MSCI USA Health Care), at 2.54%. Anyone who holds an ETF containing Pfizer also has an indirect stake in the company.
Data and Charts: Pfizer
Key Data for Pfizer
Pfizer Stock Price Chart
The Pfizer chart shows daily closing prices and is set to the current year by default. The stock is up 22.6% year to date and up 25.6% over twelve months. The last recorded close on October 30, 2026, was $30.52, at 100% of the 52-week range.
Price series from our database since Aug 12, 2024, 558 daily values.
Pfizer Stock Performance
| Year to date | +22.6% | 1 year | +25.6% |
|---|---|---|---|
| 1 month | +7.0% | 3 months | +22.0% |
| Calendar year 2025 | -6.1% |
Measured in euros, Pfizer is up 28.9% year to date and up 29.9% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day.
Alysly Data Analysis: Pfizer
What ETF Is Pfizer In?
Pfizer has very high ETF coverage and is held by 24 of the 104 ETFs we track, which together follow 11 indices. That puts the stock in more ETFs than 90.2% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XUHL / XUHC | MSCI USA Health Care | 2.54% | €25.45 |
| ZPD3 | S&P Global Dividend Aristocrats | 2.07% | €20.67 |
| ZPRG | S&P Global Dividend Aristocrats | 1.90% | €19.05 |
| SPFS | MSCI World Health Care | 1.88% | €18.84 |
| XDWH | MSCI World Health Care | 1.88% | €18.82 |
| XDEV | MSCI World Value | 1.23% | €12.33 |
| WVAL | MSCI World Value | 0.88% | €8.82 |
| SXR8 | S&P 500 | 0.26% | €2.60 |
| SPYL / SPY5 | S&P 500 | 0.26% | €2.58 |
| XD9U / XD9D | MSCI USA | 0.26% | €2.56 |
| XDEW | S&P 500 Equal Weight | 0.21% | €2.09 |
| EUNL | MSCI World | 0.19% | €1.90 |
| SWWD | MSCI World | 0.19% | €1.89 |
| SPPW | MSCI World | 0.19% | €1.89 |
| XDWD / XDWL | MSCI World | 0.19% | €1.88 |
| IUSQ | MSCI ACWI | 0.17% | €1.70 |
| WIMI | MSCI World IMI | 0.17% | €1.67 |
| SPYY | MSCI ACWI | 0.16% | €1.65 |
| SPYI / SPSA | MSCI ACWI IMI | 0.14% | €1.39 |
The last column shows how much of €1,000 in one of these funds goes to Pfizer, based on each fund's latest holdings list.
US-listed ETFs holding Pfizer (weight per latest SEC filing): VYM 0.58%, IVV 0.21%, SPY 0.21%, VOO 0.21%, VTI 0.19%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
Pfizer Weight in iShares Core MSCI World (EUNL) Since 2019
In iShares Core MSCI World (EUNL), Pfizer had a weight of 0.48% on Sep 30, 2019 and 0.19% on Oct 29, 2026. The fund tracks the MSCI World. Its share peaked at 0.60% on Jun 30, 2022. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Pfizer overlaps with the rest of a portfolio.
Which Tracked Investors Hold Pfizer?
Pfizer is not among the largest purchases in the quarter ending Jun 30, 2026. The list is led by GOOGL, DAL and NEBIUS GROUP N.V. The only manager we track that holds Pfizer reduced its position.
| Investor | Shares | Value | Quarter |
|---|---|---|---|
| Bridgewater Associates | 180,092 | $4M | reduced by 832,662 |
As of Jun 30, 2026. Based on quarterly filings with the US securities regulator, submitted up to 45 days after the reference date. The change counts shares, not price gains.
Stocks With ETF Exposure Similar to Pfizer
| Stock | Shared ETFs | r | 1 year | Annualized volatility | Net margin | Revenue growth |
|---|---|---|---|---|---|---|
| Pfizer | – | – | +25.6% | 23.9% | 12.4% | -1.6% |
 Bristol-Myers Squibb Company | 24 | +0.66 | +37.0% | 28.4% | 14.6% | -0.2% |
| Cooper Companies | 22 | – | -15.1% | 33.3% | 9.2% | +5.1% |
 Zimmer Biomet Holdings | 22 | – | -5.1% | 29.5% | 8.6% | +7.2% |
 CVS Health Corporation | 22 | – | +17.7% | 33.6% | 0.4% | +7.8% |
 Cigna Group | 22 | – | +20.7% | 30.5% | 2.2% | +11.2% |
 Elevance Health | 22 | – | +30.5% | 34.7% | 2.8% | +12.5% |
 Biogen | 22 | +0.61 | +69.5% | 32.1% | 13.1% | +2.2% |
 Labcorp Holdings | 21 | – | +43.2% | 23.7% | 6.3% | +7.2% |
These stocks reach a portfolio through largely the same funds as Pfizer. “Shared ETFs” counts the funds that hold both.
Return and volatility are calculated from our daily closing prices in US dollars. Margin and growth come from each company's latest SEC annual filing. Because fiscal years do not end on the same date for every company, the underlying periods are not fully identical.
Fundamental Analysis: Pfizer
Pfizer Key Financials
Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025).
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| FY ended Dec 2023 | 59.6 | 2.1 | 3.6% |
| FY ended Dec 2024 | 63.6 | 8.0 | 12.6% |
| FY ended Dec 2025 | 62.6 | 7.8 | 12.4% |
Technical Analysis: Pfizer
Pfizer Risk Metrics
The close on Oct 30, 2026, was the highest since our series began on Aug 12, 2024. When the S&P 500 rose or fell 1%, Pfizer moved 0.21% on average in the same direction (past 252 trading days). The correlation of 0.12, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Pfizer.
What Pfizer Correlates With
| Instrument | r | −1 … +1 |
|---|---|---|
| Bristol-Myers Squibb Company | +0.66 | |
| Amgen Inc. | +0.63 | |
| Eli Lilly and Company | +0.63 | |
| Gilead Sciences Inc. | +0.62 | |
| Biogen Inc. | +0.61 | |
| Royalty Pharma Plc Class A | +0.61 | |
| Johnson Controls International plc | -0.44 | |
| Qnity Electronics Inc. | -0.44 | |
| Arista Networks Inc | -0.42 |
The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio.
